Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026”

TOKYO, April 10, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it has been selected as a “Digital Transformation Stocks (DX Stocks) 2026” by the Ministry of Economy, Trade and Industry (METI), Tokyo Stock Exchange (TSE), and Information-technology Promotion Agency, Japan (IPA). The DX Stock program recognizes companies listed on the TSE that have established internal frameworks to promote DX linked to the enhancement of corporate value and have demonstrated outstanding digital utilization, with selections made for each industry sector. Chugai has been selected for four consecutive years since 2020, and following its designation as a “DX Platinum Enterprise 2023-2025,” it has been continuously selected for seven consecutive years since the inception of the program through this year.

The DX Stock selection is based on evaluations from the perspectives of DX realization capabilities, stakeholder engagement, and contribution to corporate value. Chugai was recognized for its alignment of management vision with DX strategy, company-wide talent development and transformation, and proactive external communication, as well as its practical initiatives toward delivering new value, including across-all-fronts AI utilization by all employees, transformation of clinical development, and the deployment of personalized healthcare (PHC) solutions.

Chugai has formulated its growth strategy “TOP I 2030” to realize its vision of becoming a top innovator in the healthcare industry, built on two pillars: “Global first-class drug discovery” and “Futuristic business model.” DX is positioned as one of the Key Drivers of this strategy. To advance DX, Chugai will transform its business and deliver healthcare solutions that will change society by building on the three basic strategies set forth in “CHUGAI DIGITAL VISION 2030”—“Strengthen digital infrastructure,” “Optimize the entire value chain,” and “Create innovative new drugs utilizing digital technologies”—while continuously evolving its strategy in response to changes in technology and the business environment, including the formulation of the new Chugai AI Strategy.

[References]

• CHUGAI DIGITAL website
  https://www.chugai-pharm.co.jp/english/innovation/digital/
• CHUGAI DIGITAL official note (in Japanese only)
  https://note.chugai-pharm.co.jp/